Small Molecule
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
72
NCT02700373
A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 31, 2016
Completion: Jan 31, 2018
NCT04853823
A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB
Start: Nov 1, 2021
Completion: Dec 1, 2022
Loading map...